Suppr超能文献

前列腺 PDT 剂量学。

Prostate PDT dosimetry.

机构信息

Department of Radiation Oncology, University of Pennsylvania, 3400 Spruce Street/2 Doner Bldg., Philadelphia, PA 19104, USA.

出版信息

Photodiagnosis Photodyn Ther. 2006 Dec;3(4):234-46. doi: 10.1016/j.pdpdt.2006.08.002. Epub 2006 Oct 19.

Abstract

We provide a review of the current state of dosimetry in prostate photodynamic therapy (PDT). PDT of the human prostate has been performed with a number of different photosensitizers and with a variety of dosimetry schemes. The simplest clinical light dose prescription is to quantify the total light energy emitted per length (J/cm) of cylindrical diffusing fibers (CDF) for patients treated with a defined photosensitizer injection per body weight. However, this approach does not take into account the light scattering by tissue and usually underestimates the local light fluence rate, and consequently the fluence. Techniques have been developed to characterize tissue optical properties and light fluence rates in vivo using interstitial measurements during prostate PDT. Optical methods have been developed to characterize tissue absorption and scattering spectra, which in turn provide information about tissue oxygenation and drug concentration. Fluorescence techniques can be used to quantify drug concentrations and photobleaching rates of photosensitizers.

摘要

我们提供了一份关于前列腺光动力疗法(PDT)中剂量学的现状综述。已经使用了许多不同的光敏剂和各种剂量学方案来进行人类前列腺 PDT。最简单的临床光剂量处方是量化每个长度(J/cm)的圆柱形扩散光纤(CDF)发出的总光能,用于接受特定光敏剂注射的患者,按体重计算。然而,这种方法没有考虑到组织的光散射,通常会低估局部光强度,因此也会低估剂量。已经开发了一些技术,通过在前列腺 PDT 期间进行间质测量,来在体内对组织光学特性和光强度进行量化。已经开发了光学方法来对组织的吸收和散射光谱进行量化,这反过来又提供了关于组织氧合和药物浓度的信息。荧光技术可用于量化药物浓度和光敏剂的光漂白率。

相似文献

1
Prostate PDT dosimetry.
Photodiagnosis Photodyn Ther. 2006 Dec;3(4):234-46. doi: 10.1016/j.pdpdt.2006.08.002. Epub 2006 Oct 19.
2
Feasibility of interstitial diffuse optical tomography using cylindrical diffusing fibers for prostate PDT.
Phys Med Biol. 2013 May 21;58(10):3461-80. doi: 10.1088/0031-9155/58/10/3461. Epub 2013 Apr 30.
4
determination of the absorption and scattering spectra of the human prostate during photodynamic therapy.
Proc SPIE Int Soc Opt Eng. 2014 Jun 14;5315:132-142. doi: 10.1117/12.528968.
5
Integrated light dosimetry system for prostate photodynamic therapy.
Proc SPIE Int Soc Opt Eng. 2008 Jan 19;6845. doi: 10.1117/12.763806.
6
light dosimetry of interstitial PDT of human prostate.
Proc SPIE Int Soc Opt Eng. 2006 Jan 21;6139. doi: 10.1117/12.646220.
7
A heterogeneous algorithm for PDT dose optimization for prostate.
Proc SPIE Int Soc Opt Eng. 2009 Feb 18;7164:71640B. doi: 10.1117/12.809897.
8
PDT dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT).
Phys Med Biol. 2017 Dec 29;63(1):015031. doi: 10.1088/1361-6560/aa9874.
9
PDT dose dosimetry for pleural photodynamic therapy.
Proc SPIE Int Soc Opt Eng. 2013 Feb 2;8568. doi: 10.1117/12.2005198.
10
In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.
Photochem Photobiol. 2003 Jan;77(1):81-8. doi: 10.1562/0031-8655(2003)077<0081:ivopon>2.0.co;2.

引用本文的文献

1
A novel investigational preclinical model to assess fluence rate for dental oral craniofacial tissues.
Photodiagnosis Photodyn Ther. 2024 Apr;46:104015. doi: 10.1016/j.pdpdt.2024.104015. Epub 2024 Feb 18.
3
Photoacoustic visualization of the fluence rate dependence of photodynamic therapy.
Biomed Opt Express. 2020 Jul 10;11(8):4203-4223. doi: 10.1364/BOE.395562. eCollection 2020 Aug 1.
6
PDT dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT).
Phys Med Biol. 2017 Dec 29;63(1):015031. doi: 10.1088/1361-6560/aa9874.
7
P NMR Evidence for Peroxide Intermediates in Lipid Emulsion Photooxidations: Phosphine Substituent Effects in Trapping.
Photochem Photobiol. 2017 Nov;93(6):1430-1438. doi: 10.1111/php.12810. Epub 2017 Sep 4.
8
Interstitial Photodynamic Therapy-A Focused Review.
Cancers (Basel). 2017 Jan 24;9(2):12. doi: 10.3390/cancers9020012.
10
A compact fiber-optic probe-based singlet oxygen luminescence detection system.
J Biophotonics. 2017 Feb;10(2):320-326. doi: 10.1002/jbio.201600078. Epub 2016 Jul 25.

本文引用的文献

1
determination of the absorption and scattering spectra of the human prostate during photodynamic therapy.
Proc SPIE Int Soc Opt Eng. 2014 Jun 14;5315:132-142. doi: 10.1117/12.528968.
2
measurement of fluorescence emission in the human prostate during photodynamic therapy.
Proc SPIE Int Soc Opt Eng. 2005 Apr 22;5689:299-310. doi: 10.1117/12.590709.
3
light dosimetry of interstitial PDT of human prostate.
Proc SPIE Int Soc Opt Eng. 2006 Jan 21;6139. doi: 10.1117/12.646220.
4
Study of light fluence rate distribution in photodynamic therapy using finite-element method.
Proc SPIE Int Soc Opt Eng. 2006 Jan 21;6139. doi: 10.1117/12.646251.
6
Implicit and explicit dosimetry in photodynamic therapy: a New paradigm.
Lasers Med Sci. 1997 Oct;12(3):182-99. doi: 10.1007/BF02765099.
7
Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy.
Photochem Photobiol. 2006 Sep-Oct;82(5):1270-8. doi: 10.1562/2005-10-04-RA-711.
8
Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light.
Photochem Photobiol. 2006 Sep-Oct;82(5):1279-84. doi: 10.1562/2005-10-19-RA-721.
9
Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.
J Environ Pathol Toxicol Oncol. 2006;25(1-2):373-87. doi: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.230.
10
Photodynamic therapy for urological malignancies: past to current approaches.
J Urol. 2006 Apr;175(4):1201-7. doi: 10.1016/S0022-5347(05)00701-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验